Navigation Links
ReBuilder (RBRM) Files Complaints Against Stock Traders
Date:2/23/2012

CHARLES TOWN, W. Va., Feb. 23, 2012 /PRNewswire/ -- The management of ReBuilder Medical Technologies, Inc.  (Pink Sheets: RBRM) announces it has filed complaints with the U.S. Securities Exchange Commission and the The Financial Industry Regulatory Authority (FINRA) alleging certain traders of the Company shares may have engaged in the unlawful and unethical sale and trading of the Company's shares.   The firmed has hired a forensic expert to audit all stock certificates and stock trading that has occurred over the last eight (8) months.  Further information can be obtained by contacting the Company at 304-725-2202.

The company has recently experienced unexplained dips in its share price, and has uncovered instances of independent third party traders who have promised shares or sold shares, never delivered them, and refused to return their customer's money.

The company has discovered several other companies that have fallen prey to these unscrupulous independent traders.  Evidently, the traders convince their pool of customers to sell shares from prior sales and move the money to their new mark, buying on the open market, thus increasing the price, promising to give them additional shares as a reward.  The original company's shares drop when the traders sell into the market, and the scheme is repeated over and over again. 

Similar to a Ponzie scheme, these traders sometimes extort shares from companies for "awareness programs" and pay off a few of the investors who complain.  Other investors, embarrassed by being taken in when the stock price inevitably drops, just give up.

The end result for a company is a sudden increase in volume and price, followed by a drop to an even lower level than it was, and the company itself has no idea of what is happening in the background and has to deal with its original core investor's ire, and can appear incompetent.  This takes time from day to day management and makes it harder to attract new, legitimate, long term investors.

RBRM is in the DME (durable medical equipment) business of submitting claims on behalf of customers who purchase the ReBuilder device for the pain of neuropathy, peripheral neuropathy, diabetic neuropathy, and chemo induced neuropathy.  The company buys its ReBuilders directly from the manufacturer, ReBuilder Medical Inc. (www.rebuildermedical.com).

ReBuilder Medical Inc. is developing several other medical devices that RBRM is negotiating to sell to its neuropathy customers when approved by the FDA.  One of the more interesting devices is one that makes it easy and painless for the nurse to draw blood. For a 2 minute video demonstration, see  www.veinappear.com.


'/>"/>
SOURCE ReBuilder Medical Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ReBuilder Medical Technologies, Inc. Hiring! Increases Staff by 40%
2. ReBuilder Medical Technologies, Inc. Reports LOI With National DME Distributor
3. Acella Pharmaceuticals, LLC, Files Abbreviated New Drug Application (ANDA) With the U.S. Food & Drug Administration
4. Natural Alternatives International, Inc. Files Patent Infringement Claim Against DNP International Co., Inc.
5. Department of Justice files consent decree of permanent injunction against Ranbaxy
6. Oramed Pharmaceuticals Files US Patent Application for Combination Oral Treatment of Diabetes
7. Intellect Neurosciences Files Appeal in Europe in Response to Opposition Proceedings Instituted by Elan Pharmaceuticals and Wyeth/Pfizer
8. Amherst-Based Pharmaceutical Company Files Federal Lawsuit Accusing Competitor of False Claims Regarding the Efficacy of Infasurf®, its Life-Saving Respiratory Drug for Premature Infants
9. Alcohol Monitoring Systems Files Appeal With Federal Circuit Court in Patent Suit
10. Pinnacle Biologics Files for Orphan Drug Designation for PHOTOFRIN® in the Treatment of Patients with Malignant Mesothelioma.
11. Par Pharmaceutical Files Declaratory Judgment to Protect First Amendment Rights to Disseminate Truthful Information Regarding Megace® ES
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... 2016 Research ... the  "Europe Thrombocythemia Market and Competitive ... their offering.       (Logo: ... latest research Europe Thrombocythemia Market and ... comprehensive insights into Thrombocythemia pipeline products, ...
(Date:5/4/2016)... Diversified Holdings (NYSE: CODI ) ("CODI," "we," ... market businesses, announced today its consolidated operating results for ... First Quarter 2016 Highlights , Generated Cash Flow ... of $13.6 million for the first quarter of 2016; ... the first quarter of 2016; , Paid a ...
(Date:5/4/2016)... According to market research "Global Computed ... to 2022 - Industry Insights by Slice Type (High, Mid ... by P&S Market Research, the global computed tomography market ... is expected to grow at a CAGR of 5.0% during ... is expected to witness the faster growth, CAGR of 5.3%, ...
Breaking Medicine Technology:
(Date:5/6/2016)... ... ... Logically, spring weather, with its moderate humidity and temperatures, should be ideal ... hot, water on the eye surface can evaporate, creating uncomfortable dry eye symptoms. In ... one problem, according to radio show and water advocate Sharon Kleyne: Spring is also ...
(Date:5/6/2016)... ... 06, 2016 , ... From the Speaker Podium to the Exhibit Floor at ... insights on managing Customers Engagement at SpeechTek 2016 Event, taking place May 23-25 at ... a Presentation on “5 Customer Engagement Strategies to improve Customer Satisfaction in ...
(Date:5/6/2016)... , ... May 06, 2016 , ... ... to Sleepopolis.com . , Since launching in September, 2014 Sleepopolis has resided ... testing areas, which now include pillows, sheets, mattress toppers, bed frames, and more. ...
(Date:5/6/2016)... , ... May 06, 2016 , ... ... arrival of Sovaldi, which made headlines mostly for its cost despite its potential ... and moral questions surrounding the drug—part of a class called direct-acting antivirals (DAAs)—have ...
(Date:5/6/2016)... ... May 06, 2016 , ... Kenneth Cochran, DSc, RN, FACHE, ... of the South announced today that Dr. Robert Menuet, Interventional Cardiologist with Cardiovascular ... Ultrasound Guided Coronary Atherectomy. , This procedure involves the removal of ...
Breaking Medicine News(10 mins):